KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Astrana Health (ASTH) EPS (Weighted Average and Diluted) (2016 - 2025)

Astrana Health's EPS (Weighted Average and Diluted) history spans 12 years, with the latest figure at $0.19 for Q2 2025.

  • For Q2 2025, EPS (Weighted Average and Diluted) fell 52.5% year-over-year to $0.19; the TTM value through Sep 2025 reached $0.19, down 85.38%, while the annual FY2024 figure was $0.9, 30.23% down from the prior year.
  • EPS (Weighted Average and Diluted) for Q2 2025 was $0.19 at Astrana Health, up from $0.14 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $0.74 in Q3 2021 and bottomed at -$0.14 in Q4 2024.
  • The 5-year median for EPS (Weighted Average and Diluted) is $0.28 (2021), against an average of $0.28.
  • The largest annual shift saw EPS (Weighted Average and Diluted) soared 425.0% in 2023 before it plummeted 153.85% in 2024.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at $0.27 in 2021, then crashed by 129.63% to -$0.08 in 2022, then skyrocketed by 425.0% to $0.26 in 2023, then tumbled by 153.85% to -$0.14 in 2024, then skyrocketed by 235.71% to $0.19 in 2025.
  • Per Business Quant, the three most recent readings for ASTH's EPS (Weighted Average and Diluted) are $0.19 (Q2 2025), $0.14 (Q1 2025), and -$0.14 (Q4 2024).